Henry Watson

DNP Doctor of Nursing Practice,  The Johns Hopkins Hospital 

Location: India

Consulting Services

Grant Submission Legal Support Pharma-CRO-Device Biostatistics Data Science-Bioinformatics

Areas Of Interest

Symphysiotomies Frameshifts, Ribosomal Adenosine Aminohydrolase Monieziasis Spinning Sensations Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide 1 Continuous Arteriovenous Hemofiltration DCC-Netrin-1 Receptor Resistant Ovary Syndrome C4 Complement Component Tone Atonic, Muscle PMSAmantadine Cek 8 Kinase Woman's Rights Delivery Rooms Jodgamma Ro 12-1989 Urethral Stenoses Cerebrospinal Fluid Otorrhea, Post-Traumatic Bayvit, Gemfibrozilo Technique, Urological Diagnostic Traumatic Intracranial Hemorrhages Frames, Open Reading CDP-Diacylglycerol Synthase Cycles, Hydrologic Alteromonas phage PM2

Professional Narrative

Dr. Henry Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Amgen 2007
Medical Writer, Harvard Med 1989

Education

Doctor of medicine, Perelman School of Medicine 1989
Bachelor of science in nursing, Perelman School of Medicine 1989

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :